BIOXCEL THERAPEUTICS INC (BTAI:NASDAQ)

$1.29 -0.02 (-1.5267%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 58

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed BIOXCEL THERAPEUTICS INC (BTAI:NASDAQ) News Sources

BioXcel Therapeutics Announces Enrollment of First Patients in U.S. Department of War-Funded Study of BXCL501 (Sublingual Dexmedetomidine) for Treatment of Acute Stress Reactions

08-04-2026

yahoo.com

external link

How The BioXcel Therapeutics (BTAI) Story Is Shifting With BXCL501 Promise And Dilution Risks

13-04-2026

yahoo.com

external link

BioXcel Therapeutics Announces Virtual Event to Discuss Commercial Launch Plan Based on Market Opportunity Assessment for IGALMI® in the At-Home Setting

17-04-2026

yahoo.com

external link

H.C. Wainwright Adjusts BioXcel Therapeutics, Inc. (BTAI) Outlook Following Capital Structure Concerns

17-04-2026

yahoo.com

external link

BioXcel Therapeutics, Inc. (BTAI) Expected to Beat Earnings Estimates: Should You Buy?

04-05-2026

yahoo.com

external link

Verastem (VSTM) Reports Q1 Loss, Misses Revenue Estimates

07-05-2026

yahoo.com

external link

CorMedix (CRMD) Q1 Earnings and Revenues Beat Estimates

14-05-2026

yahoo.com

external link

BioXcel Therapeutics Provides Business Update and Reports First Quarter 2026 Financial Results

15-05-2026

yahoo.com

external link

BioXcel Therapeutics, Inc. (BTAI) Reports Q1 Loss, Lags Revenue Estimates

15-05-2026

yahoo.com

external link

BioXcel Therapeutics Presents New Data from SERENITY At-Home Phase 3 Trial for Agitation Associated with Bipolar Disorders or Schizophrenia at 2026 ASCP Annual Meeting

28-05-2026

yahoo.com

external link

BIOXCEL THERAPEUTICS INC (BTAI:NASDAQ) Sentiment Trend

0 25 50 75 100 70 68 64 82 86 2 46 88 3 75 08-04-2026 13-04-2026 17-04-2026 04-05-2026 07-05-2026 14-05-2026 15-05-2026 28-05-2026 #1 #2 #3 #4 #5 #6 #7 #8 #9 #10 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

BIOXCEL THERAPEUTICS INC (BTAI:NASDAQ) FAQs

toggle

What is the current price of BIOXCEL THERAPEUTICS INC (BTAI:NASDAQ)?

The current price of BIOXCEL THERAPEUTICS INC (BTAI:NASDAQ) is $1.29.


toggle

BIOXCEL THERAPEUTICS INC (BTAI:NASDAQ) absolute price change since previous trading day?

The absolute price change of BIOXCEL THERAPEUTICS INC (BTAI:NASDAQ) since the previous trading day is $-0.02.


toggle

BIOXCEL THERAPEUTICS INC (BTAI:NASDAQ) percentage price change since previous trading day?

The percentage price change of BIOXCEL THERAPEUTICS INC (BTAI:NASDAQ) since the previous trading day is -1.5267%.


toggle

What is the most recent average sentiment score for BIOXCEL THERAPEUTICS INC (BTAI:NASDAQ)?

The most recent average sentiment score for BIOXCEL THERAPEUTICS INC (BTAI:NASDAQ) is 58 out of 100.


toggle

What is the most recent average sentiment for BIOXCEL THERAPEUTICS INC (BTAI:NASDAQ)?

The most recent sentiment for BIOXCEL THERAPEUTICS INC (BTAI:NASDAQ) is .


SEC-8K** Filing Available For BIOXCEL THERAPEUTICS INC (BTAI:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Similar Securities People Also Ask

BTMD (Biote Corp)
BTAX (Biostax Corp)
CBIO (Crescent Biopharma Inc)

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.